Dr. Aditi H. Mandpe, MD

Dr. Mandpe practices at BASS Imaging Center - Walnut Creek in Walnut Creek, California.

Dr. Mandpe's NPI, 1790705531, was assigned on July 21, 2006. Dr. Mandpe graduated from University of California, Davis School of Medicine in 1992. Dr. Mandpe's California license number on file is G78083.

Dr. Mandpe's primary practice is BASS Imaging Center - Walnut Creek, at 2637 Shadelands Drive, Walnut Creek, CA 94598. The practice phone is (925) 329-3710.

Dr. Mandpe's primary practice is BASS Imaging Center - Walnut Creek in Walnut Creek, California. Dr. Mandpe is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Mandpe to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Mandpe's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mandpe practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Mandpe's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Mandpe is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Mandpe has a license on file in California.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Mandpe treats.

CMS data shows 1,748 Medicare services from Dr. Mandpe across 11 procedure codes in 2024, for 674 Medicare patients. Medicare paid $121,169 for them. Every service was in an office.

CMS counts 674 Medicare patients who saw Dr. Mandpe in 2024. The largest group is 75 to 84, with 283 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mandpe's median patient age at 60, with 48% women.

In 2024, Dr. Mandpe wrote 522 Medicare Part D claims for 229 patients. 96% of them were for generic drugs. CMS names the drug for 429 of them, across 11 drugs with 11 or more claims each, at $72,169 in total drug cost. In 2023, CMS named 421 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Mandpe for performance year 2024, reported through an alternative payment model (APM). Dr. Mandpe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Mandpe in 2017. The most frequent topics are Postoperative Complications. Dr. Mandpe's most frequent co-authors are Mark I. Block, MD, Darrell L. Cass, MD and Steven W. Cheung, MD.

CMS Open Payments shows 27 general payments to Dr. Mandpe from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Medical Device Business Services, Inc. paid the most, $692.

Dmand AI lists 4 awards for Dr. Mandpe, most recently AAO-HNS Fellow in 2012.

Dr. Mandpe graduated from University of California, Davis School of Medicine in 1992. Dr. Mandpe is a member of NHS and ACS.

Dr. Mandpe is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.